Further, the upregulation of several angiogenic mediators, such as Ang2 and VEGF, in diverse chronic inflammatory diseases and CLD [15], [25], [26], [27], [28], [29] prompted us to implicate them as noninvasive surrogate markers of CHC evolution [16], [17], [30]. This evidence concerns the gene VEGFA and cryohydrocytosis.